BEI
TXG icon

Benjamin Edwards Inc’s 10x Genomics TXG Stock Holding History

Benjamin Edwards Inc’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
51,335
-6,682
-12% -$175K 0.02% 577
2026
Q1 		$1.23M Sell
58,017
-8,047
-12% -$161K 0.01% 682
2025
Q4 		$1.08M Buy
66,064
+392
+0.6% +$5.92K 0.01% 686
2025
Q3 		$768K Sell
65,672
-9,894
-13% -$129K 0.01% 786
2025
Q2 		$875K Sell
75,566
-1,589
-2% -$14.5K 0.01% 676
2025
Q1 		$674K Buy
77,155
+7,229
+10% +$91.1K 0.01% 705
2024
Q4 		$1M Buy
69,926
+11,664
+20% +$184K 0.01% 610
2024
Q3 		$1.32M Buy
58,262
+57,948
+18,455% +$1.2M 0.02% 530
2024
Q2 		$6K Buy
314
+38
+14% +$995 ﹤0.01% 641
2024
Q1 		$10K Buy
276
+132
+92% +$5.8K ﹤0.01% 643
2023
Q4 		$8K Sell
144
-51
-26% -$2.22K ﹤0.01% 597
2023
Q3 		$8K Hold
195
– – ﹤0.01% 589
2023
Q2 		$11K Sell
195
-66
-25% -$3.57K ﹤0.01% 571
2023
Q1 		$15K Buy
261
+35
+15% +$1.63K ﹤0.01% 549
2022
Q4 		$8K Buy
226
+58
+35% +$1.9K ﹤0.01% 606
2022
Q3 		$5K Sell
168
-4
-2% -$152 ﹤0.01% 618
2022
Q2 		$8K Buy
172
+9
+6% +$467 ﹤0.01% 605
2022
Q1 		$12K Buy
163
+4
+3% +$350 ﹤0.01% 597
2021
Q4 		$24K Sell
159
-6
-4% -$919 0.01% 498
2021
Q3 		$24K Sell
165
-22
-12% -$3.78K 0.01% 387
2021
Q2 		$37K Buy
187
+28
+18% +$5.07K 0.03% 294
2021
Q1 		$29K Buy
+159
New +$27.5K 0.02% 287

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Benjamin Edwards Inc's TXG Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its 10x Genomics (TXG) stake by 12% in Q2 2026, selling an estimated $175K and leaving 51,335 shares worth $1.97M. The position accounts for 0.02% of the portfolio, ranked #577.

Benjamin Edwards Inc first reported a position in TXG in Q1 2021 and has held it in 22 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Benjamin Edwards Inc held 51,335 shares of 10x Genomics worth $1.97M as of Q2 2026.
  • Benjamin Edwards Inc sold 6,682 10x Genomics shares in Q2 2026, an estimated $175K.
  • 10x Genomics made up 0.02% of Benjamin Edwards Inc's portfolio in Q2 2026, its #577 holding.
  • Benjamin Edwards Inc first reported a position in 10x Genomics in Q1 2021 and has held it in 22 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.